Recap: Arcus Biosciences Q2 Earnings
Arcus Biosciences (NYSE:RCUS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:03 PM.
Here's what investors need to know about the announcement.
Truist Securities Maintains Buy on Arcus Biosciences, Lowers Price Target to $50
Truist Securities analyst Robyn Karnauskas maintains Arcus Biosciences (NYSE:RCUS) with a Buy and lowers the price target from $77 to $50.
52 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.
Goldman Sachs Maintains Neutral on Arcus Biosciences, Raises Price Target to $48
Goldman Sachs maintains Arcus Biosciences (NYSE:RCUS) with a Neutral and raises the price target from $43 to $48.
Earnings Scheduled For May 9, 2022
Companies Reporting Before The Bell
• Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.